68Ga-PSMA PET in the Renal Cell Carcinoma
Condition(s):Renal Cancer; Metastases; PSMA PETLast Updated:January 26, 2024Recruiting
Include Studies Not Open or Pending
Condition(s):Renal Cancer; Metastases; PSMA PETLast Updated:January 26, 2024Recruiting
Condition(s):Renal Tumor Histology; Kidney Cancer; Renal Cell Carcinoma; Familial Renal Cancer; HLRCC; VHL Syndrome; BAP1 Tumor Predisposition Syndrome; FLCN Gene Mutation; ALK Gene Mutation; FH Gene Mutation; Birt-Hogg-Dube Syndrome; MET Gene Mutation; Cutaneous Leiomyoma; Cutaneous Leiomyomata With Uterine LeiomyomataLast Updated:August 31, 2023Recruiting
Condition(s):Renal Cell CancerLast Updated:June 7, 2023Recruiting
Condition(s):Renal Cell Carcinoma; Renal Cell Carcinoma MetastaticLast Updated:November 29, 2022Recruiting
Condition(s):Kidney NeoplasmsLast Updated:March 13, 2024Recruiting
Condition(s):Renal Cell CarcinomaLast Updated:October 23, 2023Not yet recruiting
Condition(s):Renal Cell Carcinoma; Clear Cell Renal Cell CarcinomaLast Updated:July 12, 2021Not yet recruiting
Condition(s):Renal CancerLast Updated:July 7, 2023Recruiting
Condition(s):Kidney CancerLast Updated:January 30, 2024Recruiting
Condition(s):Metastatic Renal Cell CarcinomaLast Updated:January 11, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.